Early switching to ofatumumab avoids a rebound effect after natalizumab cessation in multiple sclerosis patients.
- DOI
- 10.1177/20552173261487860
- Published
- 2026 Jul-Sep
- Container
- Multiple sclerosis journal - experimental, translational and clinical
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/20552173261487860,
title = {Early switching to ofatumumab avoids a rebound effect after natalizumab cessation in multiple sclerosis patients.},
author = {De Seze J and Bernard E and Betsch C and Nivoix Y and Bigaut K and Kremer L and Collongues N and Lanotte L and Ouallet JC},
year = {2026},
journal = {Multiple sclerosis journal - experimental, translational and clinical},
doi = {10.1177/20552173261487860},
url = {https://doi.org/10.1177/20552173261487860}
}RIS
TY - JOUR TI - Early switching to ofatumumab avoids a rebound effect after natalizumab cessation in multiple sclerosis patients. AU - De Seze J AU - Bernard E AU - Betsch C AU - Nivoix Y AU - Bigaut K AU - Kremer L AU - Collongues N AU - Lanotte L AU - Ouallet JC PY - 2026 JO - Multiple sclerosis journal - experimental, translational and clinical DO - 10.1177/20552173261487860 UR - https://doi.org/10.1177/20552173261487860 ER -
APA
J, D. S., E, B., C, B., Y, N., K, B., L, K., N, C., L, L., & JC, O. (2026). Early switching to ofatumumab avoids a rebound effect after natalizumab cessation in multiple sclerosis patients.. Multiple sclerosis journal - experimental, translational and clinical. https://doi.org/10.1177/20552173261487860